Pneumonitis clinical trials

Explore recruiting pneumonitis clinical trials.

Recruiting pneumonitis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pneumonitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

RADICAL-IO: thRee cycles of immunotherApy without raDical therapy In mediCALly InOperable stage I non-small cell lung cancer

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase 1/2 Trial to determine the safety and efficacy of Extracorporeal photopheresis as treatment for steriod-refractory immune related adverse events after immune checkpoint inhibitor therapy - ECIR

Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

The NIPA study: A randomized double-blind control clinical trial Naloxegol administration to prevent opioids induced gastrointestinal motility disturbance in brain Injured PAtients.

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Radiation during Osimertinib Treatment: a Safety and Efficacy Cohort Study (ROSE)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

An Open-Label, Multinational, Multicenter, Phase 3b/4 Study of Trastuzumab Deruxtecan in Patients With or Without Baseline Brain Metastasis With Previously-Treated Advanced/Metastatic HER2-Positive Breast Cancer (DESTINY-Breast12)

Germany, Poland, Spain, Denmark, Belgium, Ireland +2 more

Phase III and phase IV (Integrated) EU CTIS Study details

Thoracic Radiotherapy plus Durvalumab in Elderly and/or frail NSCLC stage III patients unfit for chemotherapy - Employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Pneumonitis trials by city

Pneumonitis in Toronto Pneumonitis in Vancouver Pneumonitis in Montreal Pneumonitis in Calgary Pneumonitis in Edmonton Pneumonitis in Ottawa Pneumonitis in Winnipeg Pneumonitis in Quebec City Pneumonitis in Hamilton Pneumonitis in Kitchener Pneumonitis in London Pneumonitis in Halifax Pneumonitis in New York Pneumonitis in Los Angeles Pneumonitis in Chicago Pneumonitis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease